Rare disease clinical trials are critical to advancing medicine but come with significant scientific, operational, and regulatory hurdles. Limited patient populations and complex approval pathways demand innovative methodologies, global collaboration, and strategic funding.
This article explores key challenges in rare disease research and strategies for successful trial execution.
